ClinicalTrials.gov record
Completed Not applicable Interventional

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)

ClinicalTrials.gov ID: NCT05174312

Public ClinicalTrials.gov record NCT05174312. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 2:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) - FASTR Trial

Study identification

NCT ID
NCT05174312
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Reprieve Cardiovascular, Inc
Industry
Enrollment
100 participants

Conditions and interventions

Interventions

  • Diuretic Drug
  • Reprieve Decongestion Management System Device

Drug · Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 10, 2022
Primary completion
Jan 9, 2025
Completion
Jan 9, 2025
Last update posted
Jul 23, 2025

2022 – 2025

United States locations

U.S. sites
16
U.S. states
10
U.S. cities
15
Facility City State ZIP Site status
Eastern Shore Research Institute Fairhope Alabama 36532
University of California Irvine Irvine California 92697
MedStar Washington Hospital Center Washington D.C. District of Columbia 20010
Trinity Health Ann Arbor Hospital Ypsilanti Michigan 48197
St. Louis VA St Louis Missouri 63130
Washington University St Louis Missouri 63130
Duke University Hospital Durham North Carolina 27710
Cone Health Greensboro North Carolina 27401
Atrium Health Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157
The Lindner Research Center at Christ Hospital Cincinnati Ohio 45219
Ohio State University Hospital Columbus Ohio 43210
Medical University of South Carolina Charleston South Carolina 29425
Prisma Health Columbia South Carolina 29203
Ascension Texas Cardiovascular Austin Texas 78705
Baylor Scott & White Dallas Texas 75246
University of Vermont Medical Center Burlington Vermont 05401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05174312, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2025 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05174312 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →